13F-HR filed by Eagle Health Investments LP
Eagle Health Investments LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-10, with 27 holding rows worth $603,308,468.
- Accession
- 0001172661-26-003205
- Filer
- CIK 1842545
- Filed
- 2026-08-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 27 entries on the cover page, a total value of $603,308,468 stated on the cover page (in dollars after the unit check, H1), rows summing to $603,308,468 with VALUE read as dollars as filed, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 76,417 | $70,897,400 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 308,143 | $53,527,521 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 300,685 | $45,111,771 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 384,130 | $40,955,941 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 624,676 | $35,743,961 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 187,413 | $32,952,828 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 555,272 | $30,539,960 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 248,322 | $30,439,311 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 884,121 | $29,520,800 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 2,060,427 | $29,155,042 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 106,158 | $28,314,462 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 120,346 | $22,538,399 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 1,181,274 | $20,554,168 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 166,148 | $19,052,191 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 65,051 | $15,922,533 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 369,164 | $15,755,920 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 297,302 | $15,577,138 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 194,577 | $15,428,010 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 256,269 | $14,845,663 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 131,344 | $12,803,413 | dollars as filed | |
| ATAIBECKLEY INC | 04650F101 | COM SHS | 1,709,359 | $9,008,322 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 235,093 | $4,344,519 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 15,847 | $4,301,668 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 1,994 | $2,391,663 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 4,390 | $1,745,815 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 46,300 | $1,470,025 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 37,686 | $410,024 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-003205 | this filing | 2026-08-10 | acceptance time not in the bulk data set |